MX2008014279A - Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b. - Google Patents
Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b.Info
- Publication number
- MX2008014279A MX2008014279A MX2008014279A MX2008014279A MX2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A MX 2008014279 A MX2008014279 A MX 2008014279A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer
- diseases
- treatment
- cell malignancies
- represent
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 12
- 201000011510 cancer Diseases 0.000 title abstract 7
- 230000036210 malignancy Effects 0.000 title abstract 5
- 238000011282 treatment Methods 0.000 title abstract 5
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 4
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 208000031888 Mycoses Diseases 0.000 abstract 2
- 230000033115 angiogenesis Effects 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000428 dust Substances 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 230000004770 neurodegeneration Effects 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609117.7A GB0609117D0 (en) | 2006-05-09 | 2006-05-09 | Novel compounds |
| PCT/EP2007/054473 WO2007128827A1 (en) | 2006-05-09 | 2007-05-09 | 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008014279A true MX2008014279A (es) | 2008-11-26 |
Family
ID=36637122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008014279A MX2008014279A (es) | 2006-05-09 | 2007-05-09 | Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100068203A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1940798A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009536934A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090005377A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101437802A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007247119A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0711092A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2651557A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0609117D0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008014279A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007128827A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090078822A (ko) * | 2006-11-09 | 2009-07-20 | 바이오티카 테크놀로지 리미티드 | 암 치료를 위한 18, 21-디데스옥시막베신 유도체 |
| US9967590B2 (en) | 2008-04-10 | 2018-05-08 | Qualcomm Incorporated | Rate-distortion defined interpolation for video coding based on fixed filter or adaptive filter |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| CN110999828A (zh) * | 2019-12-19 | 2020-04-14 | 上海海洋大学 | 改变鱼类体色分布模式的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08502488A (ja) * | 1992-10-14 | 1996-03-19 | アメリカ合衆国 | 前立腺癌および初期神経悪性疾患に対するベンゾキノイドアンサマイシンの殺腫瘍活性 |
| WO1996034525A1 (en) * | 1995-05-02 | 1996-11-07 | The Regents Of The University Of California | Inducement of thermotolerance with benzoquinonoid ansamycins |
-
2006
- 2006-05-09 GB GBGB0609117.7A patent/GB0609117D0/en not_active Ceased
-
2007
- 2007-05-09 AU AU2007247119A patent/AU2007247119A1/en not_active Abandoned
- 2007-05-09 US US12/296,537 patent/US20100068203A1/en not_active Abandoned
- 2007-05-09 BR BRPI0711092-8A patent/BRPI0711092A2/pt not_active IP Right Cessation
- 2007-05-09 JP JP2009508382A patent/JP2009536934A/ja not_active Abandoned
- 2007-05-09 CA CA002651557A patent/CA2651557A1/en not_active Abandoned
- 2007-05-09 MX MX2008014279A patent/MX2008014279A/es unknown
- 2007-05-09 EP EP07728925A patent/EP1940798A1/en not_active Withdrawn
- 2007-05-09 CN CNA2007800165888A patent/CN101437802A/zh active Pending
- 2007-05-09 KR KR1020087027546A patent/KR20090005377A/ko not_active Withdrawn
- 2007-05-09 WO PCT/EP2007/054473 patent/WO2007128827A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007128827A1 (en) | 2007-11-15 |
| KR20090005377A (ko) | 2009-01-13 |
| BRPI0711092A2 (pt) | 2011-08-23 |
| JP2009536934A (ja) | 2009-10-22 |
| US20100068203A1 (en) | 2010-03-18 |
| WO2007128827A8 (en) | 2008-01-03 |
| GB0609117D0 (en) | 2006-06-21 |
| CN101437802A (zh) | 2009-05-20 |
| EP1940798A1 (en) | 2008-07-09 |
| AU2007247119A1 (en) | 2007-11-15 |
| CA2651557A1 (en) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329001D1 (en) | 8-hydroxychinolinderivate | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| NZ589764A (en) | NMDA receptor antagonists for the treatment of neuropsychiatric disorders | |
| SI1585739T1 (sl) | Substituirani arilciklopropilacetamidi kot aktivatorji glukokinaze | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| EP4442695A3 (en) | 19-homo, 3.alpha.-hydroxy-steroid-20-one compounds for treating cns disorders | |
| GEP20115199B (en) | Phosphatidylinositol 3-kinase inhibitors and their use | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| IL181834A0 (en) | Cutting head and adaptor | |
| MX2010004435A (es) | Compuestos espiro y uso farmaceutico de los mismos. | |
| WO2005051946A3 (en) | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity | |
| GEP20125538B (en) | 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases | |
| MY141559A (en) | Triazole derivatives as tachykinin receptor antagonists | |
| SI1696905T1 (sl) | Substituirani 2-aminotetralini za preventivno zdravljenje Parkinsonove bolezni | |
| PL2152709T3 (pl) | Związki morfinanu | |
| MX2008014279A (es) | Derivados de 17-oximacbecina y su uso en el tratamiento de cancer y/o malignidades de celula b. | |
| EP4438042A3 (en) | Methods and compositions for inhibition of dihydroorotate dehydrogenase | |
| MX2013003019A (es) | Compuestos de azabenzotiazol, composiciones y metodos de uso. | |
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| MY133527A (en) | Isoquinoline derivatives | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| WO2007128829A3 (en) | 18,21-didesoxymacbecin derivatives for the treatment of cancer | |
| UA98639C2 (en) | Phosphodiesterase inhibitors | |
| MY150428A (en) | Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |